Pharmacokinetics of Modified Slow-Release Oral Testosterone Over 10 Days in Normal Men With Experimental Hypogonadism.
Latest Information Update: 01 Oct 2023
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Acronyms Oral-T-8
- 22 Aug 2013 Primary endpoint amended as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Oct 2010 Planned end date changed from 31 Oct 2010 to 1 Nov 2011 as reported by ClinicalTrials.gov.